ReviewClinical pharmacology and therapeutics2022

Evolving Acceptance and Use of RWE for Regulatory Decision Making on the Benefit/Risk Assessment of a Drug in Japan.

Kinue Nishioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.